Patents by Inventor Carlos F. Barbas

Carlos F. Barbas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7666658
    Abstract: Nine efficient aldolase antibodies were generated using hapten 2. This hapten combines, in a single molecule, structural components employed for reactive immunization with structural components employed for forming a transition state analog of the aldol reaction. Characterization of two of these antibodies reveals that they are highly proficient (up to 1000-fold better than any other antibody catalyst) and enantioselective catalysts for aldol and retro-aldol reactions and exhibit enantio- and diastereo-selectivities opposite that of antibody 38C2.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: February 23, 2010
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, Richard A. Lerner, Guofu Zhong
  • Publication number: 20100041028
    Abstract: Zinc finger-nucleotide binding polypeptides having binding specificity for target nucleotides containing one or GNN triplets are provided. Compositions containing such polypeptides and the use of such polypeptides and compositions for regulating gene expression are also provided.
    Type: Application
    Filed: February 11, 2008
    Publication date: February 18, 2010
    Applicant: The Scripps Research Institute
    Inventor: Carlos F. Barbas
  • Publication number: 20100015595
    Abstract: The present invention relates to novel methods for detecting a member of a known binding pair in a sample, including a cell, where one member of the pair (termed the “receptor”) is expressed by a bacteriophage, which phage is then used to detect the presence of the other member of the pair (termed the “ligand” or “target”). Rather than detecting the binding of the phage using antibody-based technology, the present invention relates to detecting marker molecule associated with the phage. In one aspect, the invention relates to identifying an antigen-bearing moiety (e.g., a red blood cell antigen) of interest present on a cell, e.g., a red blood cell, using antibody-displaying bacteriophage, as well as detecting anti-red blood cell auto- or alloantibodies and/or complement in a sample, using antiglobulin reagent-displaying bacteriophage and detecting a marker molecule associated with the phage. In one aspect, the phenotype of the phage is not linked with the genotype of the phage.
    Type: Application
    Filed: November 14, 2006
    Publication date: January 21, 2010
    Applicants: THE TRUSTEE OF THE UNIVERSITY OF PENNSYLVANIA, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Donald Siegel, Carlos F. Barbas, III
  • Publication number: 20090068164
    Abstract: The present invention provides a nucleotide sequence detection system in which a reporter enzyme is split into two halves each half of which is associated with at least one zinc finger domain. Upon DNA binding to the specific sequence defined by the zinc finger domains associated with the respective halves, the split-protein reassembles to reconstitute a functional enzyme. As such, the present invention provides methods of using the nucleotide sequence detection system for various diagnostic and identification purposes.
    Type: Application
    Filed: May 5, 2006
    Publication date: March 12, 2009
    Applicants: THE ARIZ BD OF REGENTS ON BEHALD OF THE UNIV OF AZ, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: David J. Segal, Indraneel Ghosh, Aik T. Ooi, Jason Porter, Cliff L. Stains, Carlos F. Barbas
  • Publication number: 20090029468
    Abstract: Polypeptides that contain zinc finger-nucleotide binding regions that bind to nucleotide sequences of the formula CNN are provided. Compositions containing a plurality of polypeptides, polynucleotides that encode such polypeptides and methods of regulating gene expression with such polypeptides, compositions and polynucleotide's are also provided.
    Type: Application
    Filed: May 9, 2008
    Publication date: January 29, 2009
    Applicant: The Scripps Research Institute
    Inventors: Carlos F. Barbas, III, Birgit Dreier
  • Publication number: 20090007300
    Abstract: The invention relates to the field of plant and agricultural technology. More specifically, the invention relates to the use of zinc finger proteins and fusions of said proteins to regulate gene expression and metabolic pathways in plants.
    Type: Application
    Filed: May 27, 2008
    Publication date: January 1, 2009
    Inventors: Carlos F. BARBAS, III, Justin T. Stege, Xueni Guan, Bipin Dalmia
  • Publication number: 20080318839
    Abstract: Fusion proteins for use as ligand-dependent transcriptional regulators are provided. The fusion proteins include a nucleotide binding domain operatively linked to a ligand-binding domain. They also can include a transcription regulating domain. The nucleotide binding domain is a zinc-finger peptide that binds to a targeted contiguous nucleotide sequence of from 3 to about 18 nucleotides are provided. The fusion proteins are used for gene therapy. Also provided are polynucleotides encoding the fusion proteins, expression vectors, and transfected cells.
    Type: Application
    Filed: July 22, 2008
    Publication date: December 25, 2008
    Inventors: Carlos F. Barbas, III, Michael Joseph Kadan, Roger Beerli
  • Patent number: 7442784
    Abstract: Fusion proteins for use as ligand-dependent transcriptional regulators are provided. The fusion proteins include a nucleotide binding domain operatively linked to a ligand-binding domain. They also can include a transcription regulating domain. The nucleotide binding domain is a zinc-finger peptide that binds to a targeted contiguous nucleotide sequence of from 3 to about 18 nucleotides are provided. The fusion proteins are used for gene therapy. Also provided are polynucleotides encoding the fusion proteins, expression vectors, and transfected cells.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: October 28, 2008
    Assignees: The Scripps Research Institute, Novartis AG
    Inventors: Carlos F. Barbas, III, Michael Joseph Kadan, Roger Beerli
  • Publication number: 20080213249
    Abstract: The present invention is directed to methods for formation of a chemically programmed antibody comprising the steps of: (1) reacting a conjugate comprising a signal module covalently linked to a proadapter with a catalytic moiety selected from the group consisting of a catalytic antibody and a Fab fragment of a catalytic antibody, wherein the proadapter includes therein a precursor to a reactive moiety activated to a reactive moiety by a reaction catalyzed by the catalytic moiety; and (2) crosslinking the reactive moiety to a side chain of an amino acid residue in the active site of the catalytic moiety to produce the chemically programmed antibody. The invention also encompasses chemically programmed antibodies formed by these methods, methods for their use, and pharmaceutical compositions, as well as proadaptors and conjugates including them. Chemically programmed antibodies are useful for the treatment of cancer, particularly in metastasis.
    Type: Application
    Filed: July 6, 2007
    Publication date: September 4, 2008
    Applicant: THE SCRIPPS RESEARCH INSITUTE
    Inventors: Subhash C. Sinha, Carlos F. Barbas, Richard A. Lerner
  • Patent number: 7378510
    Abstract: The invention relates to nucleic acids encoding synthetic zinc finger proteins for gene regulation in plants. The invention also relates to methods of producing synthetic zinc finger protein in host cells.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: May 27, 2008
    Assignees: The Scripps Research Institute, Syngenta Participations AG
    Inventors: Carlos F. Barbas, III, Justin T. Stege, Xueni Guan, Bipin Dalmia
  • Patent number: 7364737
    Abstract: Human monoclonal antibodies and fragments thereof which bind, neutralize and provide passive immunotherapy to respiratory syncytial virus (RSV) antigenic subgroups A and B are disclosed. Also disclosed are diagnostic and immunotherapeutic methods of using the monoclonal antibodies as well as cell line producing the monoclonal antibodies.
    Type: Grant
    Filed: January 29, 2004
    Date of Patent: April 29, 2008
    Assignee: The Scripps Research Institute
    Inventors: Dennis R. Burton, Carlos F. Barbas, III, Robert M. Chanock, Brian R. Murphy, James E. Crowe, Jr.
  • Patent number: 7329728
    Abstract: Fusion proteins for use as ligand-dependent transcriptional regulators are provided. The fusion proteins include a nucleotide binding domain operatively linked to a ligand-binding domain. They also can include a transcription regulating domain. The nucleotide binding domain is a zinc-finger peptide that binds to a targeted contiguous nucleotide sequence of from 3 to about 18 nucleotides are provided. The fusion proteins are used for gene therapy. Also provided are polynucleotides encoding the fusion proteins, expression vectors, and transfected cells.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: February 12, 2008
    Assignees: The Scripps Research Institute, Novartis AG
    Inventors: Carlos F. Barbas, III, Michael Joseph Kadan, Roger Beerli
  • Patent number: 7329541
    Abstract: Zinc finger-nucleotide binding polypeptides having binding specificity for target nucleotides containing one or GNN triplets are provided. Compositions containing such polypeptides and the use of such polypeptides and compositions for regulating gene expression are also provided.
    Type: Grant
    Filed: February 10, 2006
    Date of Patent: February 12, 2008
    Assignee: The Scripps Research Institute
    Inventor: Carlos F. Barbas
  • Patent number: 7151201
    Abstract: The invention relates to the field of plant and agricultural technology. More specifically, the invention relates to the use of zinc finger proteins and fusions of said proteins to regulate gene expression and metabolic pathways in plants.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: December 19, 2006
    Assignees: The Scripps Research Institute, Syngenta Participations AG
    Inventors: Carlos F. Barbas, III, Justin T. Stege, Xueni Guan, Bipin Dalmia
  • Patent number: 7118866
    Abstract: Filamentous phage comprising a matrix of cpVIII proteins encapsulating a genome encoding first and second polypeptides of an antogenously assembling receptor, such as an antibody, and a receptor comprised of the first and second polypeptides surface-integrated into the matrix via a filamentous phage coat protein membrane anchor domain fused to at least one of the polypeptides.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: October 10, 2006
    Assignee: The Scripps Research Institute
    Inventors: Angray Kang, Carlos F. Barbas, III, Richard A. Lerner
  • Patent number: 7101972
    Abstract: Zinc finger-nucleotide binding polypeptides having binding specificity for target nucleotides containing one or GNN triplets are provided. Compositions containing such polypeptides and the use of such polypeptides and compositions for regulating gene expression are also provided.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: September 5, 2006
    Assignee: The Scripps Research Institute
    Inventor: Carlos F. Barbas
  • Patent number: 7087409
    Abstract: A humanized murine antibody is provided. The amino acid sequences of a light chain complementarity determining region from a mouse antibody are grafted onto a human light chain, and a heavy chain complementarity determining region from a mouse antibody are grafted onto a human antibody heavy chain to produce libraries from which a humanized murine antibody having the desired specificity is selected.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: August 8, 2006
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, III, Christoph Rader
  • Patent number: 7067284
    Abstract: The present invention describes methods for producing antibody libraries, and particularly for increasing antibody library diversity by inducing mutagenesis within the CDR regions of immunoglobulin heavy or light chains that are displayed on the surface of filamentous phage particles comprising the library. The invention also describes oligonucleotides useful for increasing the library diversity, and universal light chains useful in the library production methods.
    Type: Grant
    Filed: July 5, 2000
    Date of Patent: June 27, 2006
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, Dennis R. Burton, Richard A. Lerner
  • Patent number: 7067617
    Abstract: Polypeptides that contain from 2 to 12 zinc finger-nucleotide binding regions that bind to nucleotide sequences of the formula (ANN)2–12 are provided. Polynucleotides that encode such polypeptides and methods of regulating gene expression with such polypeptides and polynucleotides are also provided.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: June 27, 2006
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, III, Birgit Dreier
  • Patent number: 7011972
    Abstract: Single chain, monomeric polypeptide gene switches are provided. The gene switches include ligand binding domains and at least one functional domain. Preferred functional domains are DNA binding domains and transcriptional regulating domains. Methods of regulating gene function using the switches are also provided.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: March 14, 2006
    Assignee: The Scripps Research Institute
    Inventors: Carlos F. Barbas, III, Roger Beerli, Ulrich Schopfer